Chinese guidelines for diagnosis and treatment of subarachnoid hemorrhage 2019
10.3760/cma.j.issn.1006-7876.2019.12.004
- VernacularTitle: 中国蛛网膜下腔出血诊治指南2019
- Collective Name:Chinese Society of Neurology;Chinese Stroke Society;Neurovascular Intervention Group of Chinese Society of Neurology
- Publication Type:Guideline
- Keywords:
Subarachnoid hemorrhage;
Aneurysm;
Vasospasm;
Diagnosis;
Treatment outcome;
Guide books
- From:
Chinese Journal of Neurology
2019;52(12):1006-1021
- CountryChina
- Language:Chinese
-
Abstract:
Subarachnoid hemorrhage (SAH) is a common hemorrhagic cerebrovascular disease, which causes devastating blow to the central nervous system and has a serious impact on many other organs. SAH is characterized by a variety of causes, complicated pathophysiology, different clinical symptoms, rapid progression of disease, various complications, complex clinical outcomes and high mortality. Since the publication of the Chinese guidelines for diagnosis and treatment of subarachnoid hemorrhage 2015, the results of some high-quality clinical studies at home and abroad have been released one after another. In order to guide the normative diagnosis and treatment of SAH in China with the latest evidence-based medical evidences, the Chinese Stroke Society and the Neurovascular Intervention Group of Chinese Society of Neurology organized experts to formulate the Chinese guidelines for diagnosis and treatment of subarachnoid hemorrhage 2019. This guideline updates and rewrites the etiology, processes of diagnosis and treatment, treatment methods of aneurysm and cerebral arteriovenous malformation, prevention and treatment of related complications, etc.
